Verbatim response from ChatGPT
Short answer: it varies a lot by drug, dose, and pharmacy, but in the U.S. typical out‑of‑pocket cash costs (no insurance) are roughly:
- Wegovy (semaglutide, weight‑loss 2.4 mg weekly): about $1,200–$1,600 per month
- Ozempic (semaglutide, diabetes 0.5–1 mg weekly): about $700–$1,100 per month
- Rybelsus (oral semaglutide daily): about $600–$1,000 per month
- Mounjaro (tirzepatide, diabetes): about $900–$1,400 per month
- Zepbound (tirzepatide for weight‑loss): similar to Mounjaro, often $1,000–$1,500 per month
- Saxenda (liraglutide for weight‑loss): about $1,000–$1,400 per month
- Trulicity (dulaglutide): about $500–$900 per month
- Bydureon (exenatide, weekly): roughly $500–$900 per month
Why ranges? Price depends on the exact dose/pen size, how many pens are needed per month, your local pharmacy, and periodic manufacturer pricing changes.
Ways to lower cost
- Manufacturer savings cards and patient assistance programs: e.g., Novo Nordisk (Ozempic, Wegovy, Rybelsus, Saxenda) and Eli Lilly (Mounjaro, Trulicity, Zepbound) list savings options on their websites — note many are for commercially insured patients and often exclude Medicare/Medicaid.
- Coupon services: GoodRx, SingleCare, and pharmacy discount cards can cut cash prices materially.
- Pharmacy shopping: prices can differ between chains and local pharmacies.
- Patient assistance / copay foundations: some makers or nonprofit programs will help eligible low‑income patients.
- Clinical trials or weight‑management programs (sometimes provide study drug at no cost).
Safety note: avoid buying injectable drugs from unverified online sellers or international marketplaces — stick to licensed U.S. pharmacies.
If you want, tell me which specific GLP‑1 (brand and dose) and your ZIP code and I can look up current cash prices or typical coupons for nearby pharmacies.